India’s Biotechnology Sector, Major Contributors and Challenges

Context: The India BioEconomy Report, released by the Department of Biotechnology, highlights the status of India’s bioeconomy.

India’s Biotechnology Sector Status

Current Value and Growth

India’s bioeconomy was valued at $165 billion in 2024, contributing 2% to the GDP.

• The sector has nearly doubled from $86 billion in 2020.
• It is projected to grow to $300 billion by 2030 and reach $1 trillion by 2047.

Major Contributors

• Industrial Sector: Accounts for nearly half of the bioeconomy’s value ($78 billion) through biofuels, bioplastics, and bio-based chemicals.
• Pharmaceutical Sector: Contributes 35%, mainly from vaccine production.
• Research and IT: Fastest-growing segment in 2024, including biotech software development, clinical trials, and bioinformatics.

What is Bioeconomy?

• It refers to the economic activity derived from the use of biological resources (such as plants, animals, and microorganisms) and biological processes to produce goods and services.
• It involves the sustainable use of bioresources for industrial, agricultural, and healthcare applications, contributing to economic growth while reducing environmental impact.

Key Features

• Utilizes renewable biological resources.
• Focuses on sustainable and eco-friendly production processes.
• Encourages circular economy principles by minimizing waste and maximizing resource efficiency.
• Drives innovation in areas like biofuels, bioplastics, and biopharmaceuticals.

Components

• Industrial Bioeconomy: Involves the use of biological processes and bioresources for manufacturing and industrial applications.
  • Examples: Biofuels, bioplastics, biodegradable chemicals, and industrial enzymes.
• Agricultural Bioeconomy: Focuses on enhancing agricultural productivity and sustainability using biotechnology and natural processes.
  • Examples: Genetically modified (GM) crops, bio-fertilizers, and bio-pesticides.
• Healthcare and Pharmaceutical Bioeconomy: Utilizes biological resources for drug development, medical treatments, and healthcare innovations.
  • Examples: Vaccines, biomedicines, gene therapy, and diagnostics.
• Marine and Aquatic Bioeconomy: Involves the use of marine and aquatic organisms for developing bio-based products.
  • Examples: Marine-derived pharmaceuticals, biofuels from algae, and marine enzymes.
• Environmental Bioeconomy: Focuses on improving environmental sustainability using biological solutions.
  • Examples: Bioremediation (using microbes to clean pollution), waste-to-energy conversion, and carbon capture.
• Research and Bioinformatics: Supports bioeconomy through research in biotechnology, synthetic biology, and data-driven biological solutions.
  • Examples: Genetic engineering, synthetic biology, and clinical trials using bioinformatics.

Reasons for the Growth of Bioeconomy

• Rising Demand for Sustainable Solutions: Growing concerns over climate change, environmental degradation, and resource depletion have increased the need for eco-friendly alternatives.
  • Bio-based products like bioplastics and biofuels offer sustainable replacements for fossil-based products.
• Technological Advancements in Biotechnology: Rapid progress in fields like genetic engineering, synthetic biology, and bioinformatics has expanded the scope of bio-based solutions.
  • Innovations in CRISPR gene editing and microbial fermentation have improved the efficiency of bio-manufacturing.
• Increased Investment and Government Support: Governments are promoting bioeconomy through policies and financial incentives.
  • India’s BioE3 policy (2024) aims to establish India as a global bio-manufacturing hub.
  • Biotechnology Industry Research Assistance Council (BIRAC) provides funding and infrastructure support.
• Expansion of Bio-based Industries: Growth in industries like biofuels, bioplastics, and biopharmaceuticals has boosted bioeconomy value.
  • Example: India’s ethanol production for biofuel has increased due to the Ethanol Blending Programme.
  • Increased production of vaccines and biomedicines has also driven growth.
• Cost-effectiveness and Local Availability of Bioresources: Bioresources such as plants and microorganisms are renewable, relatively cheap, and locally available.
  • Bio-based production processes are often more energy-efficient and less polluting than conventional methods.
• Global Shift Toward a Circular Economy: Focus on reducing waste and reusing resources has aligned with the principles of bioeconomy.
  • Bio-based industries contribute to circular economy goals by converting waste into valuable products (e.g., waste-to-energy projects).

Challenges Facing India’s Bioeconomy

• Regulatory Uncertainty: Lack of a clear and consistent regulatory framework for biotechnology innovations.
  • Continued reluctance to approve genetically modified (GM) crops limits agricultural productivity.
  • Complex approval processes and delays hinder the commercialization of biotech products.

• Regional Imbalance: Bioeconomy growth is concentrated in a few states like Maharashtra, Karnataka, Telangana, Gujarat, and Andhra Pradesh — contributing over two-thirds of the sector’s value.
  • Eastern and Northeastern India generate less than 6% of the total bioeconomy value.
• Limited R&D Investment: Inadequate funding for biotech research and innovation compared to global leaders like the US, China, and the EU.
• Shortage of Skilled Workforce: Lack of trained professionals in bioinformatics, synthetic biology, and biomanufacturing.

Way Ahead

By addressing policy gaps (e.g., establishing a National BioEconomy Mission, creating a single-window clearance system for biotech products) , improving infrastructure, promoting R&D, and reducing regional imbalance, India can sustain high growth rates in the bioeconomy sector.

Sharing is caring!